Focus On

SMART 2017 Milan

We will be present at the 28^th SMART Meeting, 10-12 May 2017 in Milan, the annual meeting in anesthesia and resuscitation in intensive care.

Come and meet us at our booth #30-31.

SURVIVING SEPSIS CAMPAIGN GUIDELINES 2016

The SSC guidelines are built on evidence-based medicine and are the most comprehensive guidelines available for the management of sepsis and septic shock.
Polymyxin B hemoperfusion therapy is included for the first time in the SSC guidelines, reflecting that evidence is accumulating for this therapy.

ISICEM 2017 Brussels

Estor will be present at the 37th International Symposium on Intensive Care and Emergency Medicine (ISICEM), 20th – 24th March 2017, Brussels, Belgium.
Come and meet us at our booth #1.24

EUPHRATES RCT

EUPHRATES, an RCT performed in the USA and Canada on Polymyxin B hemoperfusion therapy (Toraymyxin^®) has finished enrolment and the first results on the primary endpoints have recently been announced in a press release.

EUPHAS 2 WEB REGISTRY

EUPHAS 2 is a web-based registry for the collection of clinical data from patients undergoing Polymyxin B hemoperfusion therapy (Toraymyxin^®). Data from 357 patients recorded during the first phase have been published recently in Annals of Intensive Care Medicine.

SIAARTI 2016

We will be present at the 70th National Congress of the Italian Society of Anesthesiology and Intensive Care Medicine (SIAARTI), Naples 26-29 October. MEET THE EXPERT – Prof. Claudio Ronco at our stand Thursday 27 October at 12.30.

SIN 2016 MILAN

We will be present at the 57^th National Congress of the Italian Society of Nephrology (SIN), Milan 12-15 October. Come and meet us at our stand #16.

ESICM LIVES 2016

We are present at ESICM LIVES 2016, Milan 1-5 October. The annual congress of the European Society of Intensive Care Medicine, ESICM, is one of the largest and most influential congresses in intensive care.